Literature DB >> 31025877

Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.

Lu Xing1, Xiaoqian Zhang2, Dongdong Tong3.   

Abstract

Head and neck squamous cell carcinoma (HNSC) is a common malignancy with high mortality and poor prognosis. Alternative splicing (AS) is a transcriptional regulation mechanism that generates multiple transcripts from same genes, and aberrant AS signatures of cancers can be predictive for prognosis. We identified the survival-related AS events and splicing factors (SFs) from the RNA sequencing data and the corresponding clinical information of an HNSC cohort downloaded from The Cancer Genome Atlas (TCGA) and SpliceSeq. The independent prognostic predictors were assessed by Cox proportional regression analysis, and the regulatory network of SFs and AS events was analyzed by Spearman's test and constructed. A total of 4626 survival-related AS events in 3280 genes were identified, and most were protective factors. Among the different types of splicing events, exon skip was the most frequent. The prognostic models were constructed for each type of AS, and the area under the curve of the receiver operating characteristic curve of the combined prognostic model was 0.765, indicating good predictive performance. Finally, a correlation network between SF and AS events was constructed. We identified prognostic predictors based on AS events that stratified HNSC patients into the high- and low-risk groups, and revealed splicing networks that provide insights into the underlying mechanisms.

Entities:  

Keywords:  RNA-seq; alternative splicing; head and neck squamous cell carcinoma; prognosis; splicing factor; survival analysis

Mesh:

Substances:

Year:  2019        PMID: 31025877     DOI: 10.1089/dna.2019.4644

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  9 in total

1.  A transcriptional metabolic gene-set based prognostic signature is associated with clinical and mutational features in head and neck squamous cell carcinoma.

Authors:  Lu Xing; Mingzhu Guo; Xiaoqi Zhang; Xiaoqian Zhang; Feng Liu
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-17       Impact factor: 4.553

2.  Loss of TACC1 variant25 inducing cell proliferation and suppressing autophagy in head and neck squamous carcinoma.

Authors:  Pan Xu; Ran Zhao; Chen-Yang Zhang; Qian-Qian Zhang; Yong Wang; Jun Zhu; Wei-Wen Jiang
Journal:  Cell Death Discov       Date:  2021-12-11

3.  Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma.

Authors:  Xinyuan Zhao; Shanshan Si; Xiaona Li; Wenjuan Sun; Li Cui
Journal:  J Cancer       Date:  2020-05-18       Impact factor: 4.207

4.  Silencing lncRNA HOXA10-AS decreases cell proliferation of oral cancer and HOXA10-antisense RNA can serve as a novel prognostic predictor.

Authors:  Xiaodong Yan; Bin Cong; Qinchao Chen; Lingyun Liu; Xidi Luan; Jianxin Du; Meng Cao
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

5.  Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.

Authors:  Ya-Sian Chang; Siang-Jyun Tu; Hui-Shan Chiang; Ju-Chen Yen; Ya-Ting Lee; Hsin-Yuan Fang; Jan-Gowth Chang
Journal:  Genes (Basel)       Date:  2020-10-31       Impact factor: 4.096

6.  Identification of an alternative splicing signature as an independent factor in colon cancer.

Authors:  Haitao Chen; Jun Luo; Jianchun Guo
Journal:  BMC Cancer       Date:  2020-09-22       Impact factor: 4.430

7.  Expression scoring of a small-nucleolar-RNA signature identified by machine learning serves as a prognostic predictor for head and neck cancer.

Authors:  Lu Xing; Xiaoqi Zhang; Xiaoqian Zhang; Dongdong Tong
Journal:  J Cell Physiol       Date:  2020-01-14       Impact factor: 6.384

Review 8.  Genetic Drivers of Head and Neck Squamous Cell Carcinoma: Aberrant Splicing Events, Mutational Burden, HPV Infection and Future Targets.

Authors:  Zodwa Dlamini; Mohammed Alaouna; Sikhumbuzo Mbatha; Ahmed Bhayat; Mzubanzi Mabongo; Aristotelis Chatziioannou; Rodney Hull
Journal:  Genes (Basel)       Date:  2021-03-15       Impact factor: 4.096

Review 9.  Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy.

Authors:  Nikolay Mehterov; Maria Kazakova; Yordan Sbirkov; Boyan Vladimirov; Nikolay Belev; Galina Yaneva; Krassimira Todorova; Soren Hayrabedyan; Victoria Sarafian
Journal:  Genes (Basel)       Date:  2021-07-18       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.